Table 3. Relative quantification of gene expression associated with treatment of olanzapine, or olanzapine + berberine, or olanzapine + metformin.
Tissue | Function | Gene | Ctrl | Olan | Olan+Ber | Olan+Met |
Brown fat | Energy expenditure | AMP-activated protein kinase-(AMPK) | 1 | 0.2984 *** | 0.7719 * | 1.0536 * |
Brown fat | Energy expenditure | Uncoupling protein 3(UCP3) | 1 | 0.6258 ** | 1.0927 * | 0.866 * |
Brown fat | Glucose metabolism | Glucose transporters 4(GLUT4/SLC2A4) | 1 | 0.2601 *** | 0.5662 ** | 0.7345 ** |
Brown fat | Glucose metabolism | Phosphoenolpyruvate carboxykinase 2(PCK2) | 1 | 0.5604 * | 0.9723 | 1.1389 * |
Brown fat | Glucose metabolism | Pyruvate kinase (PKM2) | 1 | 0.3443 *** | 0.8652 *** | 0.6787 |
Brown fat | Lipid metabolism | Estrogen sulfotransferase (EST/STE2) | 1 | 0.2364 *** | 0.5898 * | 0.2316 |
Brown fat | Lipid metabolism | Resistin (RETN) | 1 | 0.2574 *** | 0.3521 | 0.5312 ** |
Brown fat | Lipid metabolism | Fatty acid synthase (FAS) | 1 | 0.4751 ** | 0.8386 *** | 0.8412 * |
Brown fat | Lipid metabolism | Glyerol-3P acyltransferase (GPAM) | 1 | 0.4017 *** | 0.7997 * | 0.8525 |
Brown fat | Lipid metabolism | Insulin-induced gene 2 (INSIG2) | 1 | 0.5394 * | 1.2907 * | 1.0692 * |
Brown fat | Lipid metabolism | Liver X receptor alpha (LXRA/NR1H3) | 1 | 0.5285 *** | 0.867 * | 1.1585 * |
Brown fat | Lipid metabolism | Acyl-CoA dehydrogenase (ACADV1) | 1 | 0.5748 * | 0.8586 * | 1.1054 * |
Brown fat | Lipid metabolism | CCAAT/enhancer binding protein alpha (C/EBPα) | 1 | 0.4098 *** | 0.6171 * | 0.7292 * |
Brown fat | Lipid metabolism | Peroxisome proliferator activated receptor gamma(PPARγ) | 1 | 0.4375 *** | 0.6371 | 0.6995 * |
Liver | Glucose metabolism | Phosphoenolpyruvate carboxykinase 1 (PCK1) | 1 | 4.5756 *** | 2.4559 * | 3.6892 |
Liver | Lipid metabolism | Insulin-induced gene 2 (INSIG2) | 1 | 1.9591 ** | 1.5637 | 0.9216 *** |
Liver | Lipid metabolism | HMG-CoA reductase (HMGCR) | 1 | 0.4599 * | 0.8487 | 0.9876 * |
Liver | Lipid metabolism | CCAAT/enhancer binding protein alpha (C/EBPα) | 1 | 0.6867 * | 1.0102 * | 1.0423 ** |
Skeletal muscle | Energy expenditure | Uncoupling protein 3(UCP3) | 1 | 5.2725 ** | 5.8264 | 25.2141 * |
Skeletal muscle | Energy expenditure | Uncoupling protein 2(UCP2) | 1 | 0.4301 * | 0.518 | 3.7121 ** |
Skeletal muscle | Energy expenditure | PPARy coactivator-1alpha (PGC-1α) | 1 | 0.6291 * | 1.1504 * | 7.93 ** |
Skeletal muscle | Glucose metabolism | Glucose transporters 4(GLUT4/SLC2A4) | 1 | 0.6831 ** | 0.9159 * | 5.8091 ** |
Skeletal muscle | Lipid metabolism | Low-density lipoprotein receptor (LDLR) | 1 | 0.4547 ** | 0.5519 | 2.5828 ** |
Skeletal muscle | Lipid metabolism | Sterol regulatory element binding protein-1 (SREBP-1) | 1 | 4.1306 ** | 5.9079 | 34.5536 ** |
White fat | Glucose metabolism | Glucose transporters 4(GLUT4/SLC2A4) | 1 | 0.6919 * | 1.7306 | 1.1937 * * |
White fat | Lipid metabolism | CCAAT/enhancer binding protein alpha (C/EBPα) | 1 | 1.5371 ** | 2.3521 * | 2.7735 * |
White fat | Lipid metabolism | Fatty acid synthase (FAS) | 1 | 1.5579 ** | 2.8311 ** | 2.0223 * |
White fat | Lipid metabolism | Glycerol-3P acyltransferase (GPAM) | 1 | 1.2941 * | 2.9321 ** | 2.3294 ** |
White fat | Lipid metabolism | HMG-CoA reductase (HMGCR) | 1 | 0.5825 * | 0.7815 ** | 0.7125 |
White fat | Lipid metabolism | Stearoyl-CoA desaturase (SCD1) | 1 | 3.569 ** | 4.8277 * | 3.268 |
White fat | Lipid metabolism | Sterol regulatory element binding protein-1 (SREBP-1) | 1 | 0.5412 * | 1.1571 * | 1.2275 * |
White fat | Lipid metabolism | Apolipoprotein E (APOE) | 1 | 0.4891 * | 0.4128 * | 0.6056 * |
Bold numbers are significant expression changes (Olan vs. Ctrl, or Olan+Ber vs. Olan, or Olan+Met vs. Olan). * denotes significant expression change at P<0.05; ** denotes significant expression change at P<0.01; ***denotes significant expression change at P<0.001.